Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock

Wiener Klinische Wochenschrift

Volumn 116, Issue 21-22, 2004, Pages 744-749

  Hofmann, Robert ^a,b   Steinwender, Clemens ^a   Kammler, Jürgen ^a   Kypta, Alex ^a   Wimmer, Gottfried ^a   Leisch, Franz ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b I Med Abteilung mit Kardiologie   (Austria)

Author keywords

Atrial fibrillation; Cardiogenic shock; Heart failure; Intravenous amiodarone

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; VERAPAMIL;

AGED; ARTICLE; BRADYCARDIA; CARDIOGENIC SHOCK; CARDIOVASCULAR INFLAMMATION; CLINICAL EXAMINATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; DISEASE EXACERBATION; DRUG INFUSION; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEALTH CENTER; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART PROARRHYTHMIA; HEART RHYTHM; HEART VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PATIENT MONITORING; PERIPHERAL VEIN; QT PROLONGATION; RECURRENT DISEASE; SINUS RHYTHM; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; SHOCK, CARDIOGENIC;

EID: 10644278945     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-004-0264-0     Document Type: Article

References (40)

1. Ehrlich JR, Nattel S, Hohnloser SH (2002) Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important disease sets. J Cardiovasc Electrophysiol 13: 399-405
2. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29: 709-715
3. Falk RH, Knowlton AA, Bernard SA (1987) Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: a randomized, double-blinded trial. Ann Intern Med 106: 503-506
4. Bigger JT, Fleiss JL, Rolnitzky LM, Merab JP, Ferrick KJ (1985) Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol 55: 623-630
5. Nattel S, Hadjis T, Talajic M (1994) The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 48: 345-371
6. Fuster V, Ryden LE, Asinger RW, et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation. J Am Coll Cardiol 38: 1231-1265
7. Donovan KD, Power BM, Hockings BEF, Dobb GJ, Lee K-Y (1995) Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 75: 693-697
8. Chapman MJ, Moran JL, O'Fathartaigh MS, Peisach AR, Cunningham DNI (1993) Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. Intensive Care Med 19: 48-52
9. Cybulski J, Kulakowski P, Makowska E, Czepiel A, Sikora-Frac M, Ceremuzynski L (1996) Intravenous Amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias. Clin Cardiol 19: 563-566
10. Galve E, Rius T, Ballester R, et al (1996) Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 27: 1079-1082
11. Clemo HF, Wood MA, Gilligan DM, Ellenbogen KA (1998) Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 81: 594-598
12. Kumar A (1996) Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. South Med J 89: 779-785
13. Cowan JC, Gardiner P, Reid DS, Newell DJ, Campbell RW (1986) A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. J Cardiovasc Pharmacol 8: 252-256
14. Hofmann R, Wimmer G, Leisch F (2000) Intravenous amiodarone bolus immediately controls heart rate in patients with atrial fibrillation accompanied by severe congestive heart failure. Heart 84: 635
15. Delle Karth G, Geppert A, Neunteufl T, et al (2001) Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29: 1149-1153
16. Cotter G, Blatt A, Kaluski E, et al (1999) Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. Eur Heart J 20: 1833-1842
17. "Sedacoron" 150 mg-Konzentrat zur Infusionszubereitung; Art der Anwendung. Austria Codex 2004
18. Ward GH, Ya Ikowsky SH (1993) Studies in phlebitis: IV: injection rate and amiodarone-induced phlebitis. J Parenter Sci Technol 47: 40-43
19. Ramus GV, Veglio F, Bonino ML, Tonda L (1991) Amiodarone and its infusion velocity in recent-onset atrial fibrillation. G Ital Cardiol 21: 1083-1091
20. Kowey PR, Levine JH, Herre JM, et al; for the Intravenous Amiodarone Multicenter Investigators Group (1995) Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation 92: 3255-3263
21. Scheinman MM, Levine JH, Cannom DS, et al; for the Intravenous Amiodarone Multicenter Investigators Group (1995) Dose-ranging study of intravenous Amiodarone in patients with life-threatening ventricular tachyarhythmias. Circulation 92: 3264-3272
22. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346: 884-890
23. Singh BN (1996) Antiarrhythmic actions of amiodarone. Am J Cardiol 78 [Suppl 4A]: 41-53
24. Hughes M, Binning A (2000) Intravenous amiodarone in intensive care. Time for a reappraisal? Intensive Care Med 26: 1730-1739
25. Roden DM (1999) Mechanisms underlying variability in response to drug therapy: implications for amiodarone use. Am J Cardiol 84: 29R-36R
26. Hohnloser SH, Meinerts: T, Dammbacher T, et al (1991) Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 121: 89-95
27. Connolly SJ (1999) Evidence-based analysis of amiodarone efficacy and safety. Circulation 100: 2025-2034
28. Mayr AJ, Dünser MW, Ritsch N, et al (2004) High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study. Wien Klin Wochenschr 116: 310-317
29. Bianconi L, Castro A, Dinelli M, et al (2000) Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. Eur Heart J 21: 1265-1273
30. Martínez-Marcos FJ, García-Garmendia JL, Ortega-Carpio A, Fernández-Gómez JM, Santos JM, Camacho C (2000) Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 86: 950-953
31. Thomas SP, Guy D, Wallace E, et al (2004) Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. Am Heart J 147: e3
32. Wenzel V, Krismer AC, Mayr VD, Voelckel WG, Strohmenger HU, Lindner KH (2001) Medikamentöse Therapie bei der kardiopulmonalen Reanimation. Wien Klin Wochenschr 113: 915-926
33. Kosinski EJ, Albin JB, Young E, Lewis SM, Leland OS Jr (1984) Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 4: 565-570
34. Ammar A, Wong M, Singh BN (1995) Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease. Am J Cardiol 75: 465-469
35. Gallik DM, Singer I, Meissner MD, Molnar J, Somberg JC (2002) Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol 90: 964-968
36. Somberg JC, Timar S, Bailin SJ, et al (2004) Lack of hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol 93: 576-581
37. Kalantzis N, Gabriel P, Mouzas J, Tiniakos D, Tsigas D, Tiniakos G (1991) Acute amiodarone-induced hepatitis. Hepatogastroenterology 38: 71-74
38. Podrid PJ (1995) Amiodarone: reevaluation of an old drug. Ann Intern Med 122: 689-700
39. Donaldson L, Grant IS, Naysmith MR, Thomas JSJ (1998) Acute amiodarone-induced lung toxicity. Intensive Care Med 24: 626-630
40. Kharabsheh S, Abendroth CS, Kozak M (2002) Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol 89: 896-898